Checkpoint Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Checkpoint Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2015 to Q3 2024.
  • Checkpoint Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 45.1M shares, a 108% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 45.1M +23.4M +108% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 41.6M +24.4M +142% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 35M +21.8M +165% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 27M +17.5M +182% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 21.7M -64.1M -74.7% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 17.2M -67.7M -79.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 13.2M -70.6M -84.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 9.59M +1.83M +23.6% Dec 31, 2022 10-K 2024-03-22
Q3 2022 85.8M +9.63M +12.6% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 84.9M +9.16M +12.1% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 83.8M +11.6M +16.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 7.76M -54.7M -87.6% Dec 31, 2021 10-K 2023-03-31
Q3 2021 76.2M +15.3M +25.2% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 75.7M +24.8M +48.6% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 72.2M +24.1M +50.2% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 62.4M +15.4M +32.8% Dec 31, 2020 10-K 2022-03-28
Q3 2020 60.9M +29.7M +95.4% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 51M +21M +70.2% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 48M +19.2M +66.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 47M +19.9M +73.6% Dec 31, 2019 10-K 2021-03-12
Q3 2019 31.2M +4.17M +15.4% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 30M +4.85M +19.3% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 28.9M +3.87M +15.5% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 27.1M +8.56M +46.3% Dec 31, 2018 10-K 2020-03-11
Q3 2018 27M +8.63M +47% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 25.1M +6.85M +37.5% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 25M +6.8M +37.3% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 18.5M +1.09M +6.23% Dec 31, 2017 10-K 2019-03-18
Q3 2017 18.4M +1.32M +7.76% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 18.3M Jun 30, 2017 10-Q 2017-08-09
Q1 2017 18.2M Mar 31, 2017 10-Q 2017-05-10
Q4 2016 17.4M +1.44M +8.99% Dec 31, 2016 10-K 2018-03-16
Q3 2016 17M Sep 30, 2016 10-Q 2016-11-14
Q4 2015 16M Dec 31, 2015 10-K/A 2017-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.